Search Ontology:
ChEBI
(2R,3R,4R,5S,6R)-5-[(2S,3R,4S,5S)-4,5-Dihydroxy-3-[(2S,3R,4S,5S)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,4-triol
- Term ID
- CHEBI:154951
- Synonyms
-
- alpha-L-arabino-pentopyranosyl-(1->2)-alpha-L-arabino-pentopyranosyl-(1->4)-beta-D-gluco-hexopyranose
- Ara(a1-2)Ara(a1-4)b-Glc
- WURCS=2.0/2,3,2/[a2122h-1b_1-5][a211h-1a_1-5]/1-2-2/a4-b1_b2-c1
- Definition
- References
-
- GlyTouCan:G91010HW
- Ontology
- ChEBI ( EBI )
Phenotype
Phenotype resulting from (2R,3R,4R,5S,6R)-5-[(2S,3R,4S,5S)-4,5-Dihydroxy-3-[(2S,3R,4S,5S)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,4-triol
Phenotype where environments contain (2R,3R,4R,5S,6R)-5-[(2S,3R,4S,5S)-4,5-Dihydroxy-3-[(2S,3R,4S,5S)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,4-triol
Phenotype modified by environments containing (2R,3R,4R,5S,6R)-5-[(2S,3R,4S,5S)-4,5-Dihydroxy-3-[(2S,3R,4S,5S)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,4-triol
Phenotype affecting (2R,3R,4R,5S,6R)-5-[(2S,3R,4S,5S)-4,5-Dihydroxy-3-[(2S,3R,4S,5S)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,4-triol
Human Disease Model